Gilead Sciences, Inc. today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment responses of adults with HIV who are virologically ...
SAN DIEGO (AP) — SAN DIEGO (AP) — Mitek Systems Inc. (MITK) on Thursday reported profit of $1.9 million in its fiscal fourth quarter. The San Diego-based company said it had profit of 4 cents per ...
WATERLOO, Ontario (AP) — WATERLOO, Ontario (AP) — The Descartes Systems Group Inc. (DSGX) on Wednesday reported profit of $43.9 million in its fiscal third quarter. On a per-share basis, the Waterloo, ...
Media personalities and online influencers who sow social division for a living, blame the rise of assassination culture on Antifa and MAGA. Meanwhile, tech CEOs gin up fears of an AI apocalypse. But ...
OR YEHUDA, Israel (AP) — OR YEHUDA, Israel (AP) — Formula Systems (1985) Ltd. (FORTY) on Thursday reported net income of $17.3 million in its third quarter. The Or Yehuda, Israel-based company said it ...
Posts from this topic will be added to your daily email digest and your homepage feed. A new bill would hold social media platforms responsible for foreseeable algorithmic harms. A new bill would hold ...
Gilead Sciences, Inc. GILD announced that its investigational single-tablet regimen (STR) of bictegravir and lenacapavir for HIV-1 Treatment met the primary endpoint in the late-stage ARTISTRY-1 study ...
Gilead Sciences Inc. (NASDAQ: GILD) on Thursday shared topline results from the Phase 3 ARTISTRY-1 trial. The open-label trial evaluated the treatment responses of HIV patients who are virologically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback